Managers / Q3 2021 · view latest →
Cowen Prime Advisors LLC
CIK 0001875920 · 599 LEXINGTON AVENUE, 20TH FLOOR, NEW YORK, NY, 10022 · 2127027157
Summary
Cowen Prime Advisors LLC reported $269M in U.S.-listed holdings across 170 positions for Q3 2021.
Its largest position, PDFS, represents 16.6% of the portfolio.
Compared with Q2 2021, the fund opened 6 new positions and exited 3.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 80.1% · $215M
- Other · 11.3% · $31M
- US DOMESTIC · 4.6% · $12M
- ADR · 1.7% · $4M
- MLP · 1.4% · $4M
- Other · 0.9% · $2M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| RDNWRUMBLEON INC COM CL B | NEW | +109.8K | 109.8K | +$4M | $4M |
| ACCURAY INC NOTE 3.750 7/1 | NEW | +2.83M | 2.83M | +$3M | $3M |
| XGNEXAGEN INC COM | NEW | +182.9K | 182.9K | +$2M | $2M |
| DISDISNEY WALT CO COM | NEW | +10.2K | 10.2K | +$2M | $2M |
| GENERAL ELECTRIC CO COM NEW | NEW | +1.7K | 1.7K | +$173,000 | $173,000 |
| CTSOCYTOSORBENTS CORP COM NEW | NEW | +1.2K | 1.2K | +$10,000 | $10,000 |
| COGNYTE SOFTWARE LTD ORD SHS | ADDED | +5.5K | 5.7K | +$112,000 | $117,000 |
| INSEINSPIRED ENTMT INC COM | ADDED | +187.0K | 237.0K | +$2M | $3M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2021
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q2 2023 | $290M | 229 | Jul 31, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $250M | 225 | May 3, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $243M | 192 | Feb 1, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $174M | 175 | Nov 7, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $176M | 177 | Aug 1, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $238M | 178 | May 2, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $294M | 174 | Feb 8, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $269M | 170 | Nov 2, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $276M | 167 | Aug 4, 2021 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.